ZTS - Zoetis Inc Stock Analysis
Zoetis Inc (ZTS) is a publicly traded company listed on the NYSE. It operates in the Drug Manufacturers - Specialty & Generic industry, part of the broader Healthcare sector. The company has a market capitalization of 53.24B, generates annual revenue of 9.40B, and reports net income of 2.65B. As of the latest data, the stock is trading at 120.82 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock is moderately valued and aligns with market expectations for established companies. The PEG ratio is above 2, which could imply the stock is overvalued based on its growth outlook. The company uses a significant amount of debt to finance its operations, which can boost returns but adds financial risk. The stock offers a moderate dividend yield (1.65%), which may appeal to income-focused investors. The stock has average market volatility, aligning with general market movement.
Analyst recommendation stands at Hold (3.96), indicating current market sentiment. Institutional ownership is reported at 96.56%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of -30.55%, trading within a 52-week range of 117.26 - 181.85.
ZTS - Zoetis Inc
120.82
Analyst Consensus
Hold 3.96
ZTS – Analyst Rating Summary
- Strong Buy: 6
- Buy: 11
- Hold: 7
- Sell: 0
- Strong Sell: 0
- Total Analysts: 24
| Index: | S&P 500 | P/E: | 20.36 | EPS (ttm): | 5.93 | Insider Own: | 0.20% | Shs Outstand: | 441.46M | Perf Week: | 0.48% |
| Market Cap: | 53.24B | Forward P/E: | 17.71 | EPS next Y: | 6.82 | Insider Trans: | -0.07% | Shs Float: | 438.07M | Perf Month: | -15.66% |
| Income(ttm): | 2.65B | PEG: | 2.55 | EPS next Q: | 1.41 | Inst Own: | 96.56% | Short Float: | 2.53% | Perf Quarter: | -20.68% |
| Revenue(ttm): | 9.40B | P/S: | 5.67 | EPS this Y: | 7.12% | Inst Trans: | 0.63% | Short Ratio: | 3.43 | Perf Half Y: | -25.90% |
| Book/sh: | 12.23 | P/B: | 9.88 | EPS next Y: | 7.59% | ROA: | 17.96% | Short Interest: | 11.07M | Perf Year: | -30.55% |
| Cash/sh: | 4.73 | P/C: | 25.55 | EPS next 5Y: | 7.98% | ROE: | 49.87% | 52W Range: | 117.26 - 181.85 | Perf YTD: | -25.85% |
| Dividend Est.: | 1.99 (1.65%) | P/FCF: | 23.77 | EPS past 3/5Y: | 8.55% 11.91% | ROIC: | 20.92% | 52W High: | 181.85 -33.56% | Beta: | 0.99 |
| Dividend TTM: | 2.00 (1.66%) | Quick Ratio: | 2.28 | Sales past 3/5Y: | 5.98% 8.14% | Gross Margin: | 70.29% | 52W Low: | 117.26 3.04% | Perf 5Y: | -26.86% |
| Dividend Ex-Date: | Oct 31, 2025 | Current Ratio: | 3.64 | EPS Y/Y TTM: | 11.51% | Oper. Margin: | 37.63% | RSI (14): | 21.44 | Volatility: | 1.86% 2.05% |
| Employees: | 13800 | Debt/Eq: | 1.35 | Sales Y/Y TTM: | 2.68% | Profit Margin: | 28.21% | Recom: | 1.57 | Target Price: | 172.64 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 1.35 | EPS Q/Q: | 8.17% | Payout: | 32.86% | Rel Volume: | 0.91 | Prev Close: | 121.16 |
| Sales Surprise: | -0.41% | EPS Surprise: | 4.88% | Sales Q/Q: | 0.50% | Earnings: | Nov 04 BMO | Avg Volume: | 3.23M | Price: | 120.82 |
| SMA20: | -10.10% | SMA50: | -14.26% | SMA200: | -21.72% | Undervalued: 42.89% | Volume: | 2,952,387 | Change: | -0.28% | |
Graham Classic formula value: 130.25
(P/E=8 * 1g) Min value: 85.09
(current P/E * 2g) Max value: 193.4
Average value: 136.25
About Zoetis Inc
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.